Literature DB >> 1490743

Standards of therapy for urinary tract infections in adults.

A R Ronald1, L E Nicolle, G K Harding.   

Abstract

Therapeutic standards have not been well defined for many forms of bacterial urinary tract infection. In women with uncomplicated infections, these exist for bacterial cystitis and for acute pyelonephritis. For most other categories of illness, among patients with complicated infections, no treatment regimens have been determined. As a result, well-designed clinical trials for these patient populations should be a priority.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1490743     DOI: 10.1007/bf01704364

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  32 in total

1.  Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. The Inter-Nordic Urinary Tract Infection Study Group.

Authors: 
Journal:  Scand J Infect Dis       Date:  1988

Review 2.  Short-term treatment of uncomplicated lower urinary tract infections in women.

Authors:  S R Norrby
Journal:  Rev Infect Dis       Date:  1990 May-Jun

Review 3.  Urinary tract infections in men. Epidemiology, pathophysiology, diagnosis, and treatment.

Authors:  B A Lipsky
Journal:  Ann Intern Med       Date:  1989-01-15       Impact factor: 25.391

4.  Acute pyelonephritis associated with bacteriuria during long-term catheterization: a prospective clinicopathological study.

Authors:  J W Warren; H L Muncie; M Hall-Craggs
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

Review 5.  Use of quinolones in urinary tract infections and prostatitis.

Authors:  K G Naber
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

Review 6.  Interpretation and comparison of treatment studies for uncomplicated urinary tract infections in women.

Authors:  S D Fihn; W E Stamm
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

7.  Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women.

Authors:  F Garlando; S Rietiker; M G Täuber; M Flepp; B Meier; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1987-02       Impact factor: 5.191

8.  Therapy for women hospitalized with acute pyelonephritis: a randomized trial of ampicillin versus trimethoprim-sulfamethoxazole for 14 days.

Authors:  J R Johnson; M F Lyons; W Pearce; P Gorman; P L Roberts; N White; P Brust; R Olsen; J W Gnann; W E Stamm
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

Review 9.  Urinary tract infections in women: diagnosis and treatment.

Authors:  J R Johnson; W E Stamm
Journal:  Ann Intern Med       Date:  1989-12-01       Impact factor: 25.391

10.  Fever, bacteremia, and death as complications of bacteriuria in women with long-term urethral catheters.

Authors:  J W Warren; D Damron; J H Tenney; J M Hoopes; B Deforge; H L Muncie
Journal:  J Infect Dis       Date:  1987-06       Impact factor: 5.226

View more
  4 in total

Review 1.  Optimal treatment of urinary tract infections in elderly patients.

Authors:  C A Wood; E Abrutyn
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

2.  Single-dose fosfomycin trometamol versus 5-day cephalexin regimen for treatment of uncomplicated lower urinary tract infections in women.

Authors:  G Elhanan; H Tabenkin; R Yahalom; R Raz
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

3.  One bolus dose of gentamicin and early oral therapy versus cefotaxime and subsequent oral therapy in the treatment of febrile urinary tract infection.

Authors:  K Sundman; P Arneborn; L Blad; L Sjöberg; T Vikerfors
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-06       Impact factor: 3.267

Review 4.  A Meta-Analysis on Clinical Outcomes of Ceftolozane versus Piperacillin in Combination with Tazobactam in Patients with Complicated Urinary Tract Infections.

Authors:  Muhammad Waqas Saeed; Syed Wasif Gillani; Rana Kamran Mahmood; Prasanna Vippadapu; Mian Waqar Hussain; Hassaan Anwer Rathore
Journal:  Biomed Res Int       Date:  2022-08-08       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.